A major role in this development of the immunosuppressive state in MM patients has been attributed to an increased expression of immune checkpoint molecules that negatively regulate T-cell function, such as PDCD1, CTLA4, BTLA and T-cell immunoglobulin and ITIM domains (TIGIT) on T cells (5–7). The gene discussed is BTLA; the disease is Miyoshi myopathy.